Preparing for Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01)

Funding Opportunity ID: 295486
Opportunity Number: RFA-HL-18-018
Opportunity Title: Preparing for Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.233
93.837
93.838
93.839
93.840
Eligible Applicants: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed if based in Canada. Non-Canadian foreign components are not allowed.
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Jul 14, 2017
Close Date: Dec 04, 2017
Last Updated Date: Jul 14, 2017
Award Ceiling: $350,000
Award Floor:
Estimated Total Program Funding: $3,847,000
Expected Number of Awards: 7
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support investigators performing research to identify the barriers and facilitators to implementation of an evidence-based practice(s) for heart, lung, blood, and sleep (HLBS) diseases in the inpatient setting. NHLBI is seeking applications that will utilize an implementation research framework to develop an implementation strategy (or strategies) to be tested during a subsequent hybrid effectiveness-implementation trial. During this grant, investigators will measure the baseline or usual care practice with respect to the evidence-based practice(s) of interest and plan for the subsequent trial. This FOA intends to support applications that propose a multidisciplinary research team that includes both inpatient clinical research expertise and implementation research expertise. At the conclusion of this U01, awardees and other qualified applicants may be ready to apply to a separate NHLBI-funded FOA, described in NOT-HL-17-493, to support the trial.
Version: Synopsis 1

Powered by WPeMatico